•ΆŒ£
Clark, D. B. & Agras, W.S. (1991). The assessment and treatment of performance anxiety in musicians [see comments] . American  Journal Psychiatry 148,5, 598-605. 
Bandelow B, Hajak G, Holzrichter S et alF Assessing the efficacy of treatment for panic disorder and agoraphobia ‡U, The Panic and a Agoraphobia Scale. Int Clin Psychopharmacol 10F73-81, 1995
Davidson, J.R.,Potts, N.L.S., Richichi, E.A., Ford, S.M., Krishnan, K.R.R., Smith, R.D. & Wilson, W.(1991).The brief social phobia scale. Journal of Clinical Psychiatry 52(suppl 11),48-51.
Davidson JRT, Potts N, Richichi E et al.(1993). Treatment of social phobia with clonazepam and placebo. Journal of Clinical  Psychopharmacology 13, 423-428.
De Vane, C.L., Ware, M.R., Emmanual, N.P., et al.(1995) The evaluation of the safety, efficacy, and physiological effects of fluvoxamine in social phobia. Presented at the 34th Annual Meeting of the American College of Neuropsychopharmacology, 11-15. San Juan, Puerto Rico.
Fahlen, T., Nilsson, H.L., Borg, K., et al.(1995). Social phobia: the clinical efficacy and tolerability of the monoamine oxidase-A and serotonin uptake inhibitor brofaromine: a double-blind, placebo-controlled study. Acta Psychiatrica Scandinavica 92, 351-358.
Gelernter, C.H., Uhde, T.W., Cimbolic, P., Arnkoff, D.B., Vittone, B.J., Tancer, M.E., & Bartko, J.J.(1991) Cognitive-behabioral and pharmacological treatments of social phobia. Archives of General Psychiatry 48, 938-945.
Graeff, F.G., Guimeras, T.S., & De Amdrade, T.G.(1996). Role of 5-HT in stress, anxiety and depression. Pharmacology, Biochemistry and Behavior 54, 129-141.
Katzelnick, D.J., Kobak, K.A., Greist, J.H., Jefferson, J.W., Mantle, J.M., & Serlin, R.C.(1995). Sertraline for social phobia: a double-blind, placebo-controlled crossover study. American Journal of Psychiatry 152,1368-1371.
Liebowitz, M.R., (1987).Social phobia. In Modern Problems of Pharmacopsychiatry (eds. W. Poldinger, T.A. Ban & P. Pichot), 22,141-173. Kager:basel, Switzerland.
Liebowitz, M.R., Schneier, F., Campeas, R., et al.(1992). Cognitive-behavioral and phamacological treatement of social phobia: a controlled study. Archives of General Psychiatry 49,290-300.
Munjack, D.J., Bruns, J., Baltazar, P.L., et al.(1991). A pilot study of buspirone in the treatment of social phobia. J Anxiety Disord  5, 87-98.
Schneier, F.R., Johnson, J., Hornig, C.D., et al.(1992). Social phobia comorbidity and morbidity in an epidemiologic sample. Archives of General Psychiatry 49, 282-288.
Schneier, F.R., Saoud, J.B., Campeas, R., Fallon, B.A., Hollander, E., Coplan, J. & Liebowitz, M.R.(1993) Buspirone in social phobia. Journal of Clinical Psychopharmacology 13, 251-256.
Stein, M.B., Chartier, M.J., Hazen, A.L., et al.(1996) Paroxetine in the treatment of generalised social phobia: open-label treatment and double-blind placebo-controlled discontinuation. Journal of Clinical Psychopharmacology 16, 218-222.
Stein, M.B., Liebowitz, M.R., Lydiard, R.B., Pitts, C.D., Bushnell, W. & Gergel, I.(1998). Paroxetine treatment of generalized social phobia(social anxiety disorder) A randomized controlled trial . JAMA 280,708-713.
Van Ameringen, M., Mancini, C., Styan, G., et al.(1991). Relationship of social phobia with other psychiatric illness. Journal of Affective Disorders 21,93-99.
Van Ameringen, M., Mancini, C. & Wilson, C.(1996). Buspirone augmentation of selective serotonin reuptake inhibitors. Journal of Affective Disorders 39, 115-121.
van Vliet, I.M., den Boer, J.A. & Westenberg, H.G.(1994). Psychopharmacological treatment of social phobia: a double blind placebo controlled study with fluvoxamine. Psychopharmacology (Berl), 115,128-134.
Versiani, M., Nardi, A.E., Mundium, F.D., et al.(1992). Phamacotherapy of social phobia: a controlled study with maclobemide and phenelzine. British Journal Psychiatry 161, 353-360.
Versiani, M., Amrein, R. & Montgomery, S.A.(1997). Social phobia: long-term treatment outocome and prediction of response - a moclobemide study. Internationa Clin Psychopharmacology 12, 239-254.
Villarreal, G., Johnson, M.R., Rubey, R., Lydiard, B. & Ballenger, J.C.(2000). Treatment of social phobia with the dopamine agonist pergolide. Depression & Anxiety 11,45-47.

@